indications for glp 1 agonists The GLP-1 and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy nice glp 1 guidelines View
Description
stayed on the prescribed starting dose for four weeks
How much weight can I expect to lose on the medicine
In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)
Davies MJ, DAlessio DA, Fradkin J, et al
